New Horizons in Mycoplasma genitalium Treatment

Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium

(2017) Magnus Unemo et al.   Nature Reviews Urology

Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium : Impact on Treatment Outcome and Resistance

(2016) Tim R. H. Read et al.   CLINICAL INFECTIOUS DISEASES

Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany

(2016) Roger Dumke et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Successful outcome of macrolide-resistantMycoplasma genitaliumurethritis after spectinomycin treatment: a case report

(2016) Lars Falk et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States

(2016) Damon Getman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

2016 European guideline onMycoplasma genitaliuminfections

(2016) J.S. Jensen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against

(2016) Patrick Horner et al.   SEXUALLY TRANSMITTED INFECTIONS

In VitroActivity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens

(2015) Douglas J. Biedenbach et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroAntibacterial Activity of AZD0914 against Human Mycoplasmas and Ureaplasmas

(2015) Ken B. Waites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Management of Mycoplasma genitalium infections – can we hit a moving target?

(2015) Jørgen Skov Jensen et al.   BMC INFECTIOUS DISEASES

Efficacy of Antimicrobial Therapy forMycoplasma genitaliumInfections

(2015) Lisa E. Manhart et al.   CLINICAL INFECTIOUS DISEASES

A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea

(2015) Edward W. Hook et al.   CLINICAL INFECTIOUS DISEASES

The Efficacy of Azithromycin for the Treatment of GenitalMycoplasma genitalium: A Systematic Review and Meta-analysis

(2015) Andrew Lau et al.   CLINICAL INFECTIOUS DISEASES

Mycoplasma genitaliumInfection and Female Reproductive Tract Disease: A Meta-analysis

(2015) Rebecca Lis et al.   CLINICAL INFECTIOUS DISEASES

Sitafloxacin: Antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV

(2015) Takashi Deguchi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains

(2014) Jørgen Skov Jensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroAntibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria

(2014) Michael D. Huband et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium-Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic Regimens

(2014) M. Bissessor et al.   CLINICAL INFECTIOUS DISEASES

Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan

(2014) M. Kikuchi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Positivity at test of cure following first-line treatment for genitalMycoplasma genitalium: follow-up of a clinical cohort

(2014) Zarin Gundevia et al.   SEXUALLY TRANSMITTED INFECTIONS

High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options

(2013) M. J. Pond et al.   CLINICAL INFECTIOUS DISEASES

Streptogramins – Two are better than one!

(2013) Yvonne Mast et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance

(2013) Deborah L Couldwell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Fluoroquinolone and Macrolide Resistance-Associated Mutations in Mycoplasma genitalium

(2013) K. A. Tagg et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Development of Doxycycline MIC and Disk Diffusion Interpretive Breakpoints and Revision of Tetracycline Breakpoints for Streptococcus pneumoniae

(2013) S. D. Dallas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis

(2013) Satoshi Takahashi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Risk of Acute Liver Injury Associated with the Use of Moxifloxacin and Other Oral Antimicrobials: A Retrospective, Population-Based Cohort Study

(2013) James A. Kaye et al.   PHARMACOTHERAPY

Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic

(2013) Carin Anagrius et al.   PLoS One

Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled Trial

(2012) Lisa E. Manhart, Catherine W. Gillespie, M. Sylvan Lowens, Christine M. Khosropour, Danny V. Colombara, Matthew R. Golden, Navneet R. Hakhu, Katherine K. Thomas, James P. Hughes, Nicole L. Jensen, Patricia A. Totten   CLINICAL INFECTIOUS DISEASES

Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin

(2012) Shin Ito et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.'

(2011) Jennifer Walker et al.   BMC INFECTIOUS DISEASES

Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical Trial

(2010) J. R. Schwebke et al.   CLINICAL INFECTIOUS DISEASES

Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance

(2010) Yasushi Shimada et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae

(2009) P. M. Roblin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR

(2009) R. Hamasuna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101

(2009) K. B. Waites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Randomized Comparison of Azithromycin and Doxycycline for the Treatment ofMycoplasma genitalium–Positive Urethritis in Men

(2009) Leandro A. Mena et al.   CLINICAL INFECTIOUS DISEASES

In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens

(2008) L. Lawrence et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study

(2008) E Jernberg et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial

(2007) E Bjornelius et al.   SEXUALLY TRANSMITTED INFECTIONS